SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Far below the surface, where light no longer reaches and noise collapses into silence, the Sperm Whale endures.  It does not rely on speed or spectacle. It survives through mass, intelligence, and absolute awareness of its surroundings.  This project is shaped by the same principle — strength formed under pressure, movement guided by understanding, and conviction built where others cannot remain.  While the surface reacts, the deep decides.

The Sperm Whale

SPERMWHALE is trending as the community debates its potential to break through previous highs and drop a zero amidst high social media activity. While some traders express skepticism regarding its longevity, others are actively encouraging aggressive accumulation and engagement to fuel a rally.

Dumb SEND IT

The $DSIT (Dumb SEND IT) community is aggressively pushing for a breakout, driven by the anticipation of official chart integration and a forthcoming website launch. Holders are actively engaged in community-led pump efforts and air-drop incentives, positioning the token as a resilient, community-driven play against skeptics and early profit-takers.

eBay, Inc. is a commerce company, whose platforms include an online marketplace and its localized counterparts, including off-platform businesses in South Korea, Japan, and Turkey, as well as eBay’s suite of mobile apps. It offers a platform for various product categories, including parts and accessories, collectibles, fashion, electronics, and home & garden. eBay generates revenue mainly through fees from sales, payment processing, and advertising. The company was founded by Pierre Morad Omidyar in September 1995 and is headquartered in San Jose, CA.

EBay Inc.

eBay Inc

eBay is trending following media reports that GameStop is building a stake in the company as a potential acquisition target, sparking widespread debate among investors over the financial feasibility and strategic logic of a merger. Community discussions are highly polarized, with many skeptical of the deal's mechanics while others are closely tracking institutional data and potential share accumulation patterns.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is currently in the spotlight following the announcement of a preliminary Phase 3 trial design for its lead candidate, CAD-1005, aimed at treating heparin-induced thrombocytopenia. While some community members are optimistic about the company's clinical pipeline and potential regulatory progress, others are expressing significant skepticism due to heavy bot-driven social media activity and concerns over the company's long-term capital needs.

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. The company was founded in 1973 and is headquartered in Paris, France.

Sanofi - ADR

Sanofi-Aventis

Sanofi is currently attracting significant investor attention as market participants speculate on the company's M&A strategy, particularly regarding potential acquisitions in the obesity, MASH, and immunology sectors. Community discourse is heavily focused on Sanofi's recent pipeline developments and the perceived need for the pharmaceutical giant to expand its portfolio to counter long-term patent cliff challenges.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending following reports that the company is preparing a potential takeover bid for eBay, fueling community speculation on how a strategic merger could transform the retailer into a larger e-commerce powerhouse. The stock is currently dominated by intense retail participation and heightened options activity as traders debate the viability of a large-scale acquisition, potential dilution, and the broader implications for the company's long-term growth trajectory.

Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The firm focuses on portfolio of neurology, inflammation, and pain medications. Its products include INDOCIN, Sympazan, Otrexup, SPRIX, CAMBIA, and Zipsor. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.

Assertio Holdings Inc

Investors are actively debating the potential for an acquisition or significant strategic shift as the company continues to hold substantial cash relative to its market capitalization. Community sentiment remains polarized, with many stakeholders expressing frustration over recent management decisions while others look for catalysts like NCCN guideline updates for Rolvedon to unlock value.

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.

Seres Therapeutics Inc

Seres Therapeutics is experiencing heightened investor attention driven by unusual volume and sustained price momentum, sparking renewed community discussions regarding potential buyout scenarios or strategic partnerships. Shareholders remain focused on whether this activity signals a significant corporate development ahead of upcoming fiscal windows, despite ongoing caution from some market participants wary of historical volatility.

Pinterest, Inc. engages in the operation of a pinboard-style photo-sharing website. It allows users to create and manage theme-based image collections such as events, interests, and hobbies. The company was founded by Benjamin Silbermann, Paul Cahill Sciarra, and Evan Sharp in October 2008 and is headquartered in San Francisco, CA.

Pinterest Inc - Ordinary Shares - Class A

Pinterest Inc

Pinterest is experiencing significant volatility as investors react to a revenue miss and cautious forward guidance, while the community actively debates whether the stock is an oversold value opportunity or a long-term play in need of new leadership. Sentiment remains divided between those betting on a technical bounce supported by the company's strong cash position and those frustrated by management's inability to capitalize on a large, active user base.

Jupiter is a cryptocurrency exchange platform on the Solana blockchain, offering features such as token swapping, limit orders, dollar-cost averaging, and a bridge for asset transfers to Solana. It provides users with tools to find the best trading prices and includes a beta version for perpetual futures trading. Jupiter finds the best price route for your swap by aggregating all the major liquidity sources on Solana.

Jupiter

Jupiter is gaining traction as community members emphasize its long-standing presence on the Solana network and its position on the JUP Strict List. Discussion centers on the project's 'joke meta' origins and a persistent effort to build long-term community engagement through regular social media interaction.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Kemper (KMPR) to Release Earnings on Wednesday

Kemper (NYSE:KMPR) will be releasing its Q1 2026 earnings after the market closes on Wednesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-6-kemper-co-stock...

Kemper Corporation $KMPR Shares Sold by Cwm LLC

Cwm LLC reduced its position in Kemper Corporation (NYSE:KMPR - Free Report) by 67.3% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 21,706...

Kemper Announces Schedule for First Quarter 2026 Earnings Release

Kemper Corporation (NYSE: KMPR) today announced that after the markets close on Wednesday, May 6, Kemper intends to issue its first quarter 2026 earnings release, financial supplement, and Form 10-Q...

Kemper Announces Sale of Newins Distribution Operation

Kemper Corporation (NYSE: KMPR) announced it has completed the sale of a property and casualty distribution operation consisting of captive agents and storefront locations to Confie, a company that...

Kemper Corporation (NYSE:KMPR) Given Average Recommendation of "Reduce" by Analysts

Shares of Kemper Corporation (NYSE:KMPR - Get Free Report) have earned an average recommendation of "Reduce" from the nine research firms that are presently covering the company, MarketBeat.com...

Kemper (NYSE:KMPR) Given New $48.00 Price Target at UBS Group

UBS Group reduced their price objective on shares of Kemper from $56.00 to $48.00 and set a "buy" rating for the company in a research report on Wednesday...

Tudor Investment Corp ET AL Increases Stock Position in Kemper Corporation $KMPR

Tudor Investment Corp ET AL grew its holdings in shares of Kemper Corporation (NYSE:KMPR - Free Report) by 64.1% during the 3rd quarter, according to its most recent 13F filing with the Securities...

SG Americas Securities LLC Boosts Holdings in Kemper Corporation $KMPR

SG Americas Securities LLC lifted its stake in shares of Kemper Corporation (NYSE:KMPR - Free Report) by 361.0% during the 4th quarter, according to its most recent disclosure with the Securities and...

Kemper Corporation $KMPR Shares Acquired by Tudor Investment Corp ET AL

Tudor Investment Corp ET AL increased its stake in Kemper Corporation (NYSE:KMPR - Free Report) by 64.1% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 223,403 shares of the insurance provider's stock af...

Kemper Corporation (NYSE:KMPR) Given Consensus Recommendation of "Reduce" by Analysts

Kemper Corporation (NYSE:KMPR - Get Free Report) has earned an average rating of "Reduce" from the eight research firms that are presently covering the company, MarketBeat Ratings reports. Four...

Kemper Corp. is a holding company, which engages in the property and casualty insurance, and life and health insurance businesses. It operates through the Specialty Property and Casualty Insurance, and Life Insurance segments. The Specialty Property and Casualty Insurance segment offers specialty automobile and commercial automobile insurance. The Life Insurance segment provides individual life, accident, supplemental health, and property insurance. The company was founded in 1967 and is headquartered in Chicago, IL.

Current Price	$34.15
Prev Close	$33.69
Open	$33.12
Dividend Yield	3.16%
50-Day Moving Average	$31.52
Beta	0.77
Avg. Volume	655,607.43
PE Ratio	15.61

52-Week High	$66.13
52-Week Low	$28.41
Market Capitalization	$2.01B
EPS (Annual)	$2.29
Price to Book	0.75
Revenue Per Employee	$648,716.22

KMPR
Kemper Corporation

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest KMPR News

KMPRKemper Corporation